HPS Pharmacies prides itself on providing innovative and informative support to assist in the diverse range of issues health professionals face on a day-to-day basis, and to facilitate the distribution of this information for a variety of sectors within the healthcare industry.
HPS’ clinical articles are written by HPS Pharmacies’ experienced and knowledgeable staff and are peer-reviewed by specialist leaders in their field to ensure the accuracy of the information provided. The resourceful and diverse range of articles play an integral role in keeping all health professionals up-to-date with the happenings throughout the industry on a regular basis.
Angiotensin-converting enzyme (ACE) inhibitors are used in the management of many conditions, including hypertension, heart failure, myocardial infarction, and diabetic nephropathy. Around 30% of individuals are intolerant to these medications, most commonly due to…
Read more
The management of coronavirus disease 2019 (COVID-19) continues to evolve as new therapies become available and new virus variants emerge. A recently published meta-analysis, including data from over 166,000 patients, examined the efficacy of…
Read more
INTRODUCTION: Migraine headaches impose a substantial level of pain and disruption to a person’s quality of life. (Malmberg-Ceder, Soinila et al. 2022) Common triggers for migraine included physical activity, poor sleep hygiene, physical and…
Read more
The Heart Foundation and the Cardiac Society of Australia and New Zealand have released the new Australian clinical guideline for diagnosing and managing acute coronary syndromes 2025. This new guideline replaces National Heart Foundation…
Read more
The Australian Institute of Health and Welfare (AIHW) recently released the report, Injury among women 2022-23. This report shows that unintentional falls are the leading cause of injury hospitalisation and death for women. In…
Read more
Dapagliflozin and empagliflozin are sodium-glucose co-transporter 2 (SGLT-2) inhibitors. These medications inhibit SGLT-2 in the renal proximal convoluted tubules. The SGLT-2 protein is responsible for the resorption of around 90% of the glucose from…
Read more
